Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
暂无分享,去创建一个
S. Debrus | I. Smolenov | A. Delem | R. Pawinski | H. Han | P. Suryakiran
[1] A. Steele,et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. , 2010, Vaccine.
[2] R. Glass,et al. Determination of the G and P types of previously nontypeable rotavirus strains from the African Rotavirus Network, 1996-2004: Identification of unusual G types. , 2010, The Journal of infectious diseases.
[3] V. Preedy,et al. Asian Rotavirus Surveillance Network , 2010 .
[4] R. Glass,et al. Global mortality associated with rotavirus disease among children in 2004. , 2009, The Journal of infectious diseases.
[5] U. Parashar,et al. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. , 2009, The Journal of infectious diseases.
[6] D. Sack,et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. , 2009, Vaccine.
[7] J. Dewar,et al. The detection and molecular characterization of human G12 genotypes in South Africa , 2009, Journal of medical virology.
[8] Y. Lau,et al. Human Rotavirus Vaccine RIX4414 (Rotarix™) Is Highly Efficacious in Infants from Asia During the First Two Years of Life , 2008 .
[9] D. M. Rivera-Medina,et al. Oral Human Rotavirus Vaccine RIX4414(Rotarix™) Co-administered with Routine EPI Vaccinations Including Oral Polio Vaccine(OPV) Is Highly Efficacious in Latin-America , 2008 .
[10] A. Delem,et al. Immunogenicity of The Oral Live Attenuated Human Rotavirus Vaccine RIX4414 (Rotarix™) Oral Suspension (Liquid Formulation) Co-administered with Childhood Vaccinations in Panama , 2008 .
[11] D. Anh,et al. Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants , 2008 .
[12] G. Irimu,et al. The epidemiology of human rotavirus associated with diarrhoea in Kenyan children: a review. , 2008, Journal of tropical pediatrics.
[13] P. Dennehy,et al. Coadministration of RIX4414 Oral Human Rotavirus Vaccine Does Not Impact the Immune Response to Antigens Contained in Routine Infant Vaccines in the United States , 2008, Pediatrics.
[14] H. Han. Safety, Reactogenicity and Immunogenicity of Live Attenuated Human Rotavirus Vaccine RIX4414 in HIV+ Infants in South Africa , 2008 .
[15] K. Maitland,et al. Incidence and Clinical Characteristics of Group A Rotavirus Infections among Children Admitted to Hospital in Kilifi, Kenya , 2008, PLoS medicine.
[16] Toyoko Nakagomi,et al. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries. , 2008, Vaccine.
[17] Felix Espinoza,et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study , 2008, The Lancet.
[18] M. C. Danovaro-Holliday,et al. Rotavirus vaccine introduction in the Americas: progress and lessons learned , 2008, Expert review of vaccines.
[19] R. Ward,et al. Why does the world need another rotavirus vaccine? , 2008, Therapeutics and clinical risk management.
[20] T. Vesikari. Rotavirus vaccines , 2008, Scandinavian journal of infectious diseases.
[21] Rotavirus surveillance--worldwide, 2001-2008. , 2008, MMWR. Morbidity and mortality weekly report.
[22] J. Bines,et al. Rotavirus vaccines must perform in low-income countries too , 2007, The Lancet.
[23] T. Vesikari,et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study , 2007, The Lancet.
[24] G. Ruiz-Palacios,et al. Efficacy of the human rotavirus vaccine RIX4414 in malnourished children. , 2007, The Journal of infectious diseases.
[25] M. O’Ryan. Rotarix™ (RIX4414): an oral human rotavirus vaccine , 2007, Expert review of vaccines.
[26] R. Glass,et al. Rotavirus vaccines: current prospects and future challenges , 2006, The Lancet.
[27] R. Glass,et al. Rotavirus and Severe Childhood Diarrhea , 2006, Emerging infectious diseases.
[28] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[29] Conclusions and recommendations from the Immunization Strategic Advisory Group. , 2006, Releve epidemiologique hebdomadaire.
[30] R. Glass,et al. Rotavirus vaccines: targeting the developing world. , 2005, The Journal of infectious diseases.
[31] K. Mølbak,et al. Characterisation of rotavirus strains among hospitalised and non-hospitalised children in Guinea-Bissau, 2002 A high frequency of mixed infections with serotype G8. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[32] A. Linhares,et al. Evaluation of Safety, Immunogenicity and Efficacy of an Attenuated Rotavirus Vaccine, RIX4414: A Randomized, Placebo-Controlled Trial in Latin American Infants , 2005, The Pediatric infectious disease journal.
[33] Roger I Glass,et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. , 2005, The Journal of infectious diseases.
[34] Y. Hoshino,et al. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine , 2005, Reviews in medical virology.
[35] J. Andrus,et al. Anticipating new vaccines in the Americas. , 2004, Revista panamericana de salud publica = Pan American journal of public health.
[36] E. Frongillo,et al. Estimates of global prevalence of childhood underweight in 1990 and 2015. , 2004, JAMA.
[37] Mark A. Miller,et al. Global Illness and Deaths Caused by Rotavirus Disease in Children , 2003, Emerging infectious diseases.
[38] J. Alexander,et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. , 2003, Vaccine.
[39] A. Steele,et al. Rotavirus strains circulating in Africa during 1996-1999: emergence of G9 strains and P[6] strains. , 2003, Vaccine.
[40] R. Glass,et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. , 2000, The Journal of infectious diseases.
[41] R. Glass,et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. , 1998, Bulletin of the World Health Organization.
[42] R. Glass,et al. Rotavirus infection in infants as protection against subsequent infections. , 1996, The New England journal of medicine.
[43] J. Eskola,et al. EUROPEAN SOCIETY FOR PAEDIATRIC INFECTIOUS DISEASES , 1991, Pediatric Research.
[44] T. Vesikari,et al. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. , 1990, Scandinavian journal of infectious diseases.
[45] T. Rockstroh,et al. [Epidemiology of Rotavirus infections]. , 1984, Polski tygodnik lekarski.
[46] A. White,et al. In this Supplement , 1935, American Journal of International Law.